Author:
Mylonakis Adam,Vailas Michail,Sakarellos Panagiotis,Karydakis Lysandros,Kyros Eleandros,Davakis Spyridon,Papalampros Alexandros,Felekouras Evaggelos
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Pancreatic neuroendocrine tumors: a review of serum biomarkers, staging, and management;Ma ZY;World J Gastroenterol,2020
2. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao JC;J Clin Oncol,2008
3. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States;Dasari A;JAMA Oncol,2017
4. Endocrine tumours of the pancreas;Oberg K;Best Pract Res Clin Gastroenterol,2005
5. Transformation of nonfunctioning pancreatic neuroendocrine carcinoma cells into insulin producing cells after treatment with sunitinib;Ohn JH;Endocrinol Metab (Seoul),2013